CEO and R&D Director
Tim Sparey & Andrew Ratcliffe
Bailey Fisher Executive Search is pleased to have worked with early stage oncology therapeutics company, Novintum Bioscience, to appoint a CEO and R&D Director.
Bailey Fisher Executive Search was engaged by Rising Tide, a US/Swiss fund, to manage the search for a CEO for Novintum Bioscience, one of their portfolio companies. The search resulted in the appointment of Tim Sparey, an experienced pharmaceutical professional with a background in blue chip, large and specialty pharma, as well as earlier stage biotech companies.
Following Tim’s appointment as CEO, Bailey Fisher was re-engaged by Novintum Bioscience to lead the search for an experienced “drug hunter” as R&D Director, to work alongside the CSO as a senior executive leader in the organisation. The search resulted in the appointment of Andrew Ratcliffe, an internationally experienced and highly motivated R&D Director.